Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery

Journal of Extra-Corporeal Technology

Volumn 37, Issue 1, 2005, Pages 9-14

  Li, Shu ^a,b,d   Ji, Hongwen ^a   Lin, Jing ^c   Lenehan, Eric ^c   Ji, Bingyang ^a   Liu, Jinping ^a   Liu, Jin ^a   Long, Cun ^a   Crane, Terry A ^b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b TEXAS HEART INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Acute preoperative plateletpheresis (APP); Aprotinin; Cardiac surgery; Cardiopulmonary bypass (CPB); Cell salvage (CS)

Indexed keywords

APROTININ; FRESH FROZEN PLASMA; HEPARIN;

ADULT; AGED; BLEEDING; BLOOD SAMPLING; BLOOD TRANSFUSION; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EVALUATION; FEMALE; HEART SURGERY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; SALVAGE THERAPY; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; TREATMENT OUTCOME;

EID: 14644425216     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Chavez AM, Cosgrove DM. Blood conservation. Semin Thorac Cardiovasc Surg. 1990;2:358-63.
2. Breyer RH, Engelman RM, Rousou JA, Lemeshow SA. A comparison of cell saver versus ultrafilter during coronary artery bypass operations. J Thorac Cardiovasc Surg. 1985;90:736-40.
3. Hall RI, Schweiger IM, Finlayson DC. The benefit of the Hemonetics cell saver apparatus during cardiac surgery. Can J Anaesth. 1990;37:618-23.
4. Boldt J, Kling D, Zickmann B, Jacobi M, Dapper F, Hempelmann G. Acute preoperative plasmapheresis and established blood conservation techniques. Ann Thorac Surg. 1990;50:62-8.
5. Gravlee GP. Autologous platelet-rich plasma in cardiac surgery: aesthetics versus virtue. J Cardiothorac Vasc Anesth. 1993;7:1-3.
6. Boldt J, Zickmann B, Ballesteros M, Oehmke S, Stertmann F, Hempelmann G. Influence of acute preoperative plasmapheresis on platelet function in cardiac surgery. J Cardiothorac Vasc Anesth. 1993;7:4-9.
7. Smith PK, Datta SK, Muhlbaier LH, Samsa G, Nadel A, Lipscomb J. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. Ann Thorac Surg. 2004;77:635-42.
8. Hu XQ, Liu MZ, Wu LM, et al. Application of different dose aprotinin on open-heart surgery. Chin Circ J. 1995;10:110-2.
9. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood. 1990;76:1680-97.
10. Spanier TB, Chen JM, Oz MC, et al. Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1998;116:860-9.
11. Gil W. Inflammo-coagulatory response, extrinsic pathway thrombin generation and a new theory of activated clotting time interpretation. Perfusion. 2001;16:27-35.
12. Gu YJ, Huyzen RJ, van Oeveren W. Extrinsic pathway-associated activated clotting time for anticoagulation monitoring during cardiopulmonary bypass. Anesth Analg. 1996;83:433.
13. Sonntag J, Dahnert I, Stiller B, Hetzer R, Lange PE. Complement and contact activation during cardiovascular operations in infants. Ann Thorac Surg. 1998;65:525-31.
14. Bertolino G, Locatelli A, Noris P, et al. Platelet composition and function in patients undergoing cardiopulmonary bypass for heart surgery. Haematologica. 1996;81:116-20.
15. Levy JH, Cormack JG, Morales A. Heparin neutralization by recombinant platelet factor 4 and protamine. Anesth Analg. 1995;81:35-7.
16. Schlame M, Schmid AB, Haupt R, Rustow B, Kox WJ. Study of platelet-activating factor acetylhydrolase in the perioperative period of patients undergoing cardiac surgery. Shock. 1998;9:313-9.
17. Rinder C, Fitch J. Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell responses. J Cardiovasc Pharmacol. 1996;27:S6-12.
18. Kawahito K, Kobayashi E, Ohmori M, et al. Enhanced responsiveness of circulatory neutrophils after cardiopulmonary bypass: increased aggregability and superoxide producing capacity. Artif Organs. 2000;24:37-42.
19. Ilton MK, Langton PE, Taylor ML, et al. Differential expression of neutrophil adhesion molecules during coronary artery surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1999;118:930-37.
20. Baufreton C, Intrator L, Jansen PG, et al. Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. Ann Thorac Surg. 1999;67:972-7.
21. Pintar T, Collard CD. The systemic inflammatory response to cardiopulmonary bypass. Anesthesiol Clin North America. 2003;21:453-64.
22. Holloway DS, Summaria L, Sandesara J, Vagher Jp, Alexander JC, Caprini JA. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost. 1988;59:62-7.
23. Wenger RK, Lukasiewicz H, Mikuta BS, Niewiarowski S, Edmunds LH. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1989;97:235-9.
24. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Simth BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology. 1991;75:563-70.
25. Mohr R, Goor DA, Lusky A, Lavee J. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfuanction. Circulation. 1992;86(Suppl 2):405-9.
26. Blauhut B, Gross C, Necek S, Doran JE, Spath P, Hansen PL. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991;101:958-67.
27. Lass M, Welz A, Kochs M, Mayer G. Schwandt M, Hannekum A. Aprotinin in elective primary bypass surgery. Graft patency and clinical efficacy. Eur J Cardiothorac Surg. 1995;9:206-10.
28. Royston D. Blood-sparing drugs: aprotinin, tranexamic acid, and epsilon-aminocaproic acid. Int Anesthesiol Clin. 1995;33:155-79.
29. Shinfeld A, Zippel D, Lavee J, et al. Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate. Ann Thorac Surg. 1995;59:872-6.